Clinical trials
Completed Acquired Immunodeficiency Syndrome trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
67 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2002 | 1 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 2 |
| 2007 | 4 |
| 2008 | 4 |
| 2009 | 4 |
| 2010 | 6 |
| 2011 | 8 |
| 2012 | 3 |
| 2013 | 3 |
| 2014 | 3 |
| 2015 | 6 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 67 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| ViiV Healthcare | 19 |
| Tibotec Pharmaceuticals, Ireland | 4 |
| Gilead Sciences | 3 |
| GlaxoSmithKline | 3 |
| Hospitales Universitarios Virgen del Rocío | 3 |
| Janssen-Cilag International NV | 3 |
| Bristol-Myers Squibb | 2 |
| Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | 2 |
| Janssen R&D Ireland | 2 |
| Sociedad Andaluza de Enfermedades Infecciosas | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Acquired Immunodeficiency Syndrome | 67 |
| HIV Infections | 29 |
| Infections | 16 |
| Hepatitis C | 5 |
| Tuberculosis | 4 |
| Hepatitis C, Chronic | 3 |
| Hepatitis B | 2 |
| Virus Diseases | 2 |
| Arthralgia | 1 |
| Bone Diseases, Metabolic | 1 |
Trials
Showing 1 to 25 of 67. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.